C. Bucșa

发表

Amino Acid Signature of Oxidative Stress in Patients with Type 2 Diabetes: Targeted Exploratory Metabolomic Research

C. Bala, D. Ciobanu, G. Roman, 2021, Antioxidants.

Drug-drug Interactions of Statins Potentially Leading to Muscle-Related Side Effects in Hospitalized Patients

D. Leucuta, D. Dumitrascu, M. Bojita, 2015, Romanian journal of internal medicine = Revue roumaine de medecine interne.

A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium–Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study

D. Leucuta, C. Mogoșan, F. Casoinic, 2022, Frontiers in Pharmacology.

NOD2-associated granulomatous autoinflammatory syndromes – a short update for clinicians

Mihaela Sparchez, M. Lupse, S. Rednic, 2021 .

An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics.

D. Moga, D. Dumitrascu, A. Farcas, 2015, European review for medical and pharmacological sciences.

Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis.

L. Mouthon, L. Arnaud, Z. Amoura, 2021, Clinical and experimental rheumatology.

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders

D. Leucuta, C. Mogoșan, Madalina Huruba, 2022, Pharmaceuticals.

Safety of Antibiotics in Hospitalized Children in Romania: A Prospective Observational Study

O. Oniga, Irina Iaru, C. Bucșa, 2022, Pharmaceuticals.

An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: A VigiBase study

D. Leucuta, C. Mogoșan, C. Bucșa, 2021, Pharmacoepidemiology and drug safety.

Combined use of renin-angiotensin-aldosterone system-acting agents: a cross-sectional study

D. Leucuta, D. Dumitrascu, C. Mogoșan, 2016, International Journal of Clinical Pharmacy.

How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients?

D. Leucuta, M. Bojita, C. Mogoșan, 2013, European journal of internal medicine.

ADVERSE EVENTS FOLLOWING MEASLES-MUMPS-RUBELLA VACCINATION. A PROSPECTIVE OBSERVATIONAL STUDY

C. Bucșa, 2020 .

Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly

D. Leucuta, C. Mogoșan, Madalina Huruba, 2021, Pharmaceuticals.

An insight into statin use and its association with muscular side effects in clinical practice

D. Leucuta, D. Dumitrascu, M. Bojita, 2015, Romanian journal of internal medicine = Revue roumaine de medecine interne.

Drug utilisation study of antidiabetic medication during 2012‐2019 in Romania

A. Rusu, C. Mogoșan, Andreea Farcas, 2021, International journal of clinical practice.

Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis

D. Leucuta, D. Dumitrascu, A. Ismaiel, 2022, Frontiers in Nutrition.

A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders

D. Leucuta, C. Mogoșan, Madalina Huruba, 2021, Scientific Reports.

Utilization of psychotropic medicines in Romania during 1998–2018

A. Cristina, C. Mogoșan, S. Armean, 2023, Frontiers in Pharmacology.

Preventability analysis of adverse drug reactions detected in two internal medicine departments in Romania

D. Leucuta, D. Dumitrascu, M. Bojita, 2014, Internal and Emergency Medicine.

Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting

C. Mogoșan, C. Bucșa, Andreea Farcaș, 2018, European Journal of Clinical Pharmacology.

Statin drug-drug interactions in a Romanian community pharmacy

D. Dumitrascu, C. Mogoșan, C. Bucșa, 2016, Clujul medical.

Safety Profile of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Hepatitis C in Romania: an Analysis Conducted in VigiBase®/ WHO.

A. Cristina, C. Mogoșan, I. Cazacu, 2020, Journal of gastrointestinal and liver diseases : JGLD.

Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

C. Chiamulera, G. Trifirò, A. Vannacci, 2023, Drug Safety.

ADVERSE REACTIONS OF THE CANTGRIP ® VACCINE

M. Bojita, C. Bucșa, D. Țățulescu, 2012 .

Concordance of pharmacist versus patient responses regarding counselling in community pharmacy.

M. Bojita, C. Mogoșan, C. Bucșa, 2021, Journal of evaluation in clinical practice.

A description of medicines-related safety issues evaluated through a referral procedure at the EU level after 2012

C. Mogoșan, C. Bucșa, Laura Anghel, 2020, Expert opinion on drug safety.

Translation, cultural adaptation and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in Romanian older adults.

D. Moga, D. Dumitrascu, A. Rusu, 2023, Research in social & administrative pharmacy : RSAP.

Counseling provided by the pharmacist in Romanian community pharmacies: the patients’ perspective

M. Bojita, C. Bucșa, M. Iancu, 2014, Clujul medical.